Compare BNL & MMED Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BNL | MMED |
|---|---|---|
| Founded | 2007 | 1983 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Real Estate Investment Trusts | Medical/Dental Instruments |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.8B | 4.1B |
| IPO Year | 2008 | 2026 |
| Metric | BNL | MMED |
|---|---|---|
| Price | $19.94 | $11.73 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 9 | 10 |
| Target Price | $20.22 | ★ $22.56 |
| AVG Volume (30 Days) | ★ 3.8M | 736.1K |
| Earning Date | 04-29-2026 | 06-03-2026 |
| Dividend Yield | ★ 5.87% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.24 | N/A |
| Revenue | ★ $454,138,000.00 | N/A |
| Revenue This Year | $7.93 | $15.99 |
| Revenue Next Year | $5.45 | $10.00 |
| P/E Ratio | $82.15 | ★ N/A |
| Revenue Growth | ★ 5.17 | N/A |
| 52 Week Low | $15.28 | $11.52 |
| 52 Week High | $20.48 | $17.86 |
| Indicator | BNL | MMED |
|---|---|---|
| Relative Strength Index (RSI) | 55.68 | 31.41 |
| Support Level | $19.72 | N/A |
| Resistance Level | $20.48 | $15.80 |
| Average True Range (ATR) | 0.34 | 0.81 |
| MACD | -0.06 | -0.13 |
| Stochastic Oscillator | 52.89 | 5.01 |
Broadstone Net Lease Inc is an internally managed real estate investment trust that invests in, owns, and manages single-tenant commercial real estate properties that are net leased on a long-term basis to a diversified group of tenants. The company has selectively invested in net leased assets in the industrial, healthcare, restaurant, retail, and office property types. The company focuses on investing in real estate that is operated by creditworthy single tenants in industries characterized by positive business drivers and trends. The company targets properties that are an integral part of the tenants' businesses and are therefore opportunities to secure long-term net leases.
Minimed Group Inc is a medical technology firm that develops, manufactures, and markets products and solutions for diabetes management. It offers automated insulin pumps, continuous glucose monitoring systems and sensors, and smart insulin pens as its main products. The company sells these through direct-to-consumer channels and healthcare providers of various countries. The company's revenues are principally derived from the sale of reusable and single-use products which together comprise AID systems and smart multiple daily injection (MDI) systems for diabetes management to individuals, distributors, healthcare providers, and other institutions globally.